Acadia Healthcare - ACHC Stock Forecast, Price & News

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $1.20 during mid-day trading on Friday, hitting $82.61. 484,147 shares of the company's stock traded hands, compared to its average volume of 627,508. The firm has a 50 day moving average of $73.79 and a two-hundred day moving average of $67.99. Acadia Healthcare has a 12 month low of $50.07 and a 12 month high of $83.63. The firm has a market capitalization of $7.50 billion, a price-to-earnings ratio of 27.09, a price-to-earnings-growth ratio of 2.12 and a beta of 1.30. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.52.

Acadia Healthcare (NASDAQ:ACHC - Get Rating) last announced its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. Acadia Healthcare had a return on equity of 10.34% and a net margin of 11.32%. The firm had revenue of $651.72 million during the quarter, compared to the consensus estimate of $650.80 million. During the same quarter in the prior year, the company earned $0.71 EPS. The firm's revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities analysts forecast that Acadia Healthcare will post 3.13 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on ACHC. Jefferies Financial Group boosted their target price on Acadia Healthcare from $85.00 to $95.00 in a research note on Thursday, July 28th. Deutsche Bank Aktiengesellschaft upped their price target on Acadia Healthcare from $70.00 to $82.00 in a research note on Monday, August 1st. UBS Group upped their price target on Acadia Healthcare from $82.00 to $90.00 and gave the stock a "buy" rating in a research note on Thursday, July 28th. Loop Capital started coverage on Acadia Healthcare in a research note on Thursday, June 16th. They set a "hold" rating and a $72.00 price target for the company. Finally, Mizuho upped their price target on Acadia Healthcare from $64.00 to $69.00 in a research note on Wednesday, May 4th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $81.89.

Insider Activity at Acadia Healthcare

In other Acadia Healthcare news, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the transaction, the director now owns 31,769 shares of the company's stock, valued at approximately $2,650,169.98. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Christopher L. Howard sold 12,214 shares of the firm's stock in a transaction on Monday, August 8th. The stock was sold at an average price of $81.67, for a total value of $997,517.38. Following the completion of the transaction, the executive vice president now directly owns 149,147 shares of the company's stock, valued at $12,180,835.49. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William M. Petrie sold 6,000 shares of the firm's stock in a transaction on Friday, July 29th. The stock was sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the transaction, the director now directly owns 31,769 shares of the company's stock, valued at $2,650,169.98. The disclosure for this sale can be found here. Insiders sold a total of 29,094 shares of company stock worth $2,375,868 in the last 90 days. 1.90% of the stock is owned by company insiders.